PeptiDream Inc (PPTDF)
14.30
+1.07
(+8.09%)
USD |
OTCM |
Jun 21, 16:00
PeptiDream Cash from Operations (Quarterly): -12.96M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -12.96M |
| December 31, 2023 | 24.93M |
| September 30, 2023 | -0.3099M |
| June 30, 2023 | 5.334M |
| March 31, 2023 | 58.58M |
| December 31, 2022 | 9.561M |
| September 30, 2022 | -6.394M |
| June 30, 2022 | -3.730M |
| March 31, 2022 | -0.0722M |
| December 31, 2021 | 0.4867M |
| September 30, 2021 | 14.86M |
| June 30, 2021 | 0.7575M |
| March 31, 2021 | 44.55M |
| December 31, 2020 | -1.741M |
| September 30, 2020 | 5.670M |
| June 30, 2020 | 9.186M |
| March 31, 2020 | 3.118M |
| September 30, 2019 | 13.59M |
| June 30, 2019 | 6.253M |
| March 31, 2019 | 13.30M |
| December 31, 2018 | 1.264M |
| Date | Value |
|---|---|
| September 30, 2018 | 19.52M |
| June 30, 2018 | 16.46M |
| March 31, 2018 | -0.6164M |
| December 31, 2017 | -4.175M |
| September 30, 2017 | -2.389M |
| June 30, 2017 | 12.92M |
| March 31, 2017 | -4.203M |
| December 31, 2016 | -1.976M |
| September 30, 2016 | 7.317M |
| June 30, 2016 | 8.236M |
| March 31, 2016 | 6.753M |
| December 31, 2015 | 2.769M |
| September 30, 2015 | -4.597M |
| June 30, 2015 | 12.76M |
| March 31, 2015 | -0.1559M |
| December 31, 2014 | -0.3622M |
| September 30, 2014 | -0.0944M |
| June 30, 2014 | 1.547M |
| March 31, 2014 | -0.2929M |
| December 31, 2013 | 0.497M |
| September 30, 2013 | -1.036M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-12.96M
Minimum
Mar 2024
58.58M
Maximum
Mar 2023
9.035M
Average
5.334M
Median
Jun 2023
Cash from Operations (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 1.999B |
| Nxera Pharma Co Ltd | -14.86M |
| Healios KK | -4.144M |
| AnGes Inc | -- |
| SanBio Co Ltd | -- |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 70.04M |
| Cash from Financing (Quarterly) | -5.103M |
| Free Cash Flow | 6.450M |
| Free Cash Flow Per Share (Quarterly) | -0.1284 |
| Free Cash Flow to Equity (Quarterly) | -1.618M |
| Free Cash Flow to Firm (Quarterly) | -16.64M |
| Free Cash Flow Yield | 0.35% |